Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Rury R Holman

Diabetes Trials Unit (DTU)

The DTU is the largest Academic Research Organisation (ARO) worldwide that specialises in performing diabetes-related mega trials. It designs, runs and analyses large-scale interventional clinical outcome trials nationally and internationally, often in collaboration with other AROs and pharmaceutical companies. The DTU also undertakes major modelling and statistical programmes to utilise fully the data available from its many studies with a particular emphasis on modelling diabetes and cardiovascular disease processes. It maintains DNA, urine and plasma biobanks and facilitates the genomic, proteomic and metabonomic evaluation of these materials. In addition, the DTU evaluates novel treatments and devices for the therapy of diabetes trials and undertakes research into potential new therapeutic agents. It is a fully registered UKCRC Clinical Trials Unit.